Organogenesis Holdings Inc. Class A Common Stock
Symbol: ORGO (NASDAQ)
Company Description:
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
- Today's Open: $3.05
- Today's High: $3.255
- Today's Low: $3.05
- Today's Volume: 919.90K
- Yesterday Close: $3.08
- Yesterday High: $3.115
- Yesterday Low: $3.005
- Yesterday Volume: 751.92K
- Last Min Volume: 400
- Last Min High: $3.18
- Last Min Low: $3.18
- Last Min VWAP: $3.18
- Name: Organogenesis Holdings Inc. Class A Common Stock
- Website: https://www.organogenesis.com
- Listed Date: 2016-11-29
- Location: CANTON, MA
- Market Status: Active
- CIK Number: 0001661181
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $378.66M
- Round Lot: 100
- Outstanding Shares: 126.85M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-05-12 | ARS | View |
2025-05-12 | DEF 14A | View |
2025-05-08 | 10-Q | View |
2025-05-08 | 8-K | View |
2025-04-29 | PRE 14A | View |
2025-04-29 | 10-K/A | View |
2025-03-27 | 8-K | View |
2025-03-17 | 144 | View |
2025-03-12 | 4 | View |
2025-03-06 | 4 | View |
2025-03-04 | 4 | View |
2025-02-27 | 10-K | View |
2025-02-27 | 8-K | View |
2025-02-21 | 4 | View |
2025-02-21 | 4 | View |
2025-02-21 | 4 | View |
2025-02-21 | 4 | View |
2025-02-21 | 4 | View |
2025-02-21 | 4 | View |
2025-02-21 | 4 | View |